Prolonged survival with systemic chemotherapy in an advanced malignant mesothelioma: A case report.

Elghali, Mohamed Amine; Bourigua, Rym; Belaid, Imtinene; Nasri, Salsabil; Mestiri, Sara; Yaacoub, Sara; Makni, Amine; Letaief, Rached

Elghali, Mohamed Amine; Bourigua, Rym; Belaid, Imtinene; Nasri, Salsabil; Mestiri, Sara; Yaacoub, Sara; Makni, Amine; Letaief, Rached.

Afiliación

Elghali MA; Department of Digestive Surgery, University of Sousse, Faculty of Medicine, Farhat Hached University Hospital, Sousse, Tunisia.
Bourigua R; Department of Medical Oncology, University of Sousse, Faculty of Medicine, Farhat Hached University Hospital, Sousse, Tunisia.
Belaid I; Department of Medical Oncology, University of Sousse, Faculty of Medicine, Farhat Hached University Hospital, Sousse, Tunisia.
Nasri S; Department of Digestive Surgery, University of Sousse, Faculty of Medicine, Farhat Hached University Hospital, Sousse, Tunisia.
Mestiri S; Department of Pathology, University of Sousse, Faculty of Medicine, Farhat Hached University Hospital, Sousse, Tunisia.
Yaacoub S; Department of Pathology, University of Sousse, Faculty of Medicine, Farhat Hached University Hospital, Sousse, Tunisia.
Makni A; Department of Digestive Surgery, University of Tunis, Faculty of Medicine, La Rabta University Hospital, Tunis, Tunisia.
Letaief R; Department of Digestive Surgery, University of Sousse, Faculty of Medicine, Farhat Hached University Hospital, Sousse, Tunisia.

Rare Tumors ; 13: 2036361320984527, 2021.

Article en En | MEDLINE | ID: mdl-33613924

Palabras clave

Peritoneal mesothelioma; chemotherapy; surgery; survival

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Rare Tumors Año: 2021 Tipo del documento: Article País de afiliación: Túnez

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google